Who are NeuroQore's investors?

NeuroQore's investors include SOSV.

How much funding has NeuroQore raised?

NeuroQore has disclosed $1.5M raised across 1 round.

Where is NeuroQore headquartered?

NeuroQore is headquartered in Mountain View, US.

NeuroQore

Mountain View, US · Delaware corporation · 1 known investors

Find your way into NeuroQore

Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroQore team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NeuroQore develops neuromodulation treatments for neurobehavioral conditions, focusing on treatment-resistant major depressive disorder and suicidality. It works with universities and research clinics to investigate new interventions as alternatives to existing treatments like rTMS and ECT.

Biotech Digital Health Medical Devices Mental Health

Founders & leadership

Adrian ChanCo-FounderAdrian Chan is an executive officer and director at NeuroQore, with expertise in biomedical engineering, signal and image processing, machine learning, and noninvasive sensor systems.

Mehran TalebinejadNamed on SEC filing

Investors · 1

SOSVlisted by SOSVNew York · $30K – $550K

How we know: open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2025

▶$1.5MraisedSep 2025 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Adrian ChanExecutive Officer, Director
Mehran TalebinejadExecutive Officer, Director

Offering amount: $1.8M
Amount sold: $1.5M
First sale: Jul 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does NeuroQore do?: NeuroQore develops neuromodulation treatments for neurobehavioral conditions, focusing on treatment-resistant major depressive disorder and suicidality. It works with universities and research clinics to investigate new interventions as alternatives to existing treatments like rTMS and ECT.
Who are NeuroQore's investors?: NeuroQore's investors include SOSV.
How much funding has NeuroQore raised?: NeuroQore has disclosed $1.5M raised across 1 round.
Where is NeuroQore headquartered?: NeuroQore is headquartered in Mountain View, US.